Samaneh Mirzaei Dahka, Maryam Afsharfar, Shirin Tajaddod, Mohammad Hassan Sohouli, Soheila Shekari, Fatemeh Bakhshi Nafouti, Atiyeh Alizadeh, Hanieh Shafahi Kachaei, Khadijeh Abbasi, Golsa Khalatbari Mohseni, Farkhondeh Alami, Maryam Gholamalizadeh, Saeid Doaei
Journal: Asian Pacific journal of cancer prevention : APJCP 2023;24(3):783-789
PMID: 36974529
BACKGROUND
Radiation dermatitis (RD) is a common side effect of radiotherapy in most breast cancer patients. Curcumin has recently attracted more attention for managing the side effects of breast cancer treatments. This review study aimed to investigate the effect of curcumin on the severity of radiation dermatitis in patients with breast cancer. Methods: All eligible randomized controlled trials (RCTs) were collected by searching PubMed, Scopus, Cochrane, and Web of Science. The effect size was expressed as weighted mean difference (WMD) and 95% confidence interval (CI). Study heterogeneity was assessed through Q statistics and I-squared.
RESULTS
Four RCTs with 882 patients were included in the final analysis. The results of the meta-analysis indicated that curcumin supplementation significantly reduced radiation dermatitis severity (RDS) score in the intervention group compared to the control group (WMD=-0.50; 95% CI -0.72 to -0.27, P <0.001). A significant heterogeneity was observed between the studies (I2 = 95.7%, P < 0.001).
CONCLUSION
Based on the results of the present study, curcumin has significant effects in reducing the severity of radiation dermatitis in breast cancer patients receiving radiotherapy. Further well-designed longitudinal studies are recommended to confirm these results and to discover the underlying mechanisms of the effects of curcumin on the severity of radiation dermatitis in patients with cancer.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.